Meanwhile, Deutsche Bank downgraded its Astrazeneca plc ADR [AZN] rating to a Sell from a a Hold in a research note published recently. A number of analysts have revised their coverage, including Goldman’s analysts, who began to cover the stock in late May with a ‘”a Buy”‘ rating. Deutsche Bank also remained covering AZN and has increased its forecast on April 16, 2024 with a “Hold” recommendation from previously “Sell” rating. Deutsche Bank revised its rating on February 08, 2024. It rated AZN as “a Sell” which previously was an “a Hold”.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Price Performance Review of AZN
On Tuesday, Astrazeneca plc ADR [NASDAQ:AZN] saw its stock fall -7.22% to $66.27. Over the last five days, the stock has lost -11.90%. Astrazeneca plc ADR shares have fallen nearly -1.60% since the year began. Nevertheless, the stocks have risen 3.61% over the past one year. While a 52-week high of $87.68 was reached on 08/30/24, a 52-week low of $60.47 was recorded on 02/12/24. SMA at 50 days reached $78.44, while 200 days put it at $74.84.
Levels Of Support And Resistance For AZN Stock
The 24-hour chart illustrates a support level at 65.19, which if violated will result in even more drops to 64.11. On the upside, there is a resistance level at 67.45. A further resistance level may holdings at 68.63. The Relative Strength Index (RSI) on the 14-day chart is 16.49, which indicates oversold technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -4.81, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 92.52%. Stochastics %K at 6.68% indicates the stock is a buying.
How much short interest is there in Astrazeneca plc ADR?
A steep rise in short interest was recorded in Astrazeneca plc ADR stocks on 2024-10-15, dropping by -2.43 million shares to a total of 4.03 million shares. Yahoo Finance data shows the prior-month short interest on 2024-09-13 was 6.45 million shares. There was a decline of -60.25%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on January 23, 2024 when Morgan Stanley began covering the stock and recommended ‘”an Overweight”‘ rating along with a $85 price target.
